07:33 AM EDT, 08/07/2024 (MT Newswires) -- Bio-Techne ( TECH ) reported fiscal Q4 adjusted earnings Wednesday of $0.49 per diluted share, down from $0.55 a year earlier.

Analysts polled by Capital IQ expected $0.49.

Revenue for the quarter ended June 30 was $306.1 million, compared with $301.3 million a year earlier.

Analysts surveyed by Capital IQ expected $306.3 million.

Meanwhile, the company maintained its quarterly dividend of $0.08 per share, payable Aug. 30 to shareholders of record on Aug. 19.